Materias dentro de su búsqueda.
Mostrando 4,261 - 4,280 Resultados de 4,918 Para Buscar '"Pfizer"', tiempo de consulta: 0.28s Limitar resultados
  1. 4261
    “…Hammond, MD, F2G: Advisor/Consultant|F2G: Grant/Research Support|GSK: Grant/Research Support|Pfizer: Advisor/Consultant|Scynexis: Grant/Research Support|Seres therapeutics: Advisor/Consultant Sophia Koo, MD, SM, Aerium Therapeutics: Advisor/Consultant|GSK: Grant/Research Support|Merck: Grant/Research Support|Scynexis: Grant/Research Support…”
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    2715. Toxicities and clinical consequences of valganciclovir prophylaxis in solid organ transplant recipients
  2. 4262
    “….: Ownership Interest|Merck: Honoraria|nomic bio: Advisor/Consultant|nomic bio: Stocks/Bonds|Pfizer: Honoraria|Scynexis Inc.: Grant/Research Support|Takeda: Advisor/Consultant|Takeda: Honoraria…”
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    584. Microbiological Outcomes of Culture-Negative Blood Specimens Using 16s rRNA Broad-Range PCR Sequencing: a Retrospective Study in a Canadian Province from 2018 to 2022
  3. 4263
    “…DISCLOSURES: Roger Paredes, M.D, Ph.D., Atea: Advisor/Consultant|Gilead: Advisor/Consultant|Lilly: Advisor/Consultant|MSD: Advisor/Consultant|MSD: Grant/Research Support|Pfizer: Advisor/Consultant|Roche: Advisor/Consultant|Theratechnologies: Advisor/Consultant|ViiV: Advisor/Consultant|ViiV: Grant/Research Support…”
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    315. An Interpretable Machine Learning Model Using The Gut Microbiome to Predict Clinical E. faecium Infection in Human Stem-Cell Transplant Recipients
  4. 4264
    “…Shields, PharmD, MS, Allergan: Advisor/Consultant|Cidara: Advisor/Consultant|Entasis: Advisor/Consultant|GSK: Advisor/Consultant|Melinta: Advisor/Consultant|Melinta: Grant/Research Support|Menarini: Advisor/Consultant|Merck: Advisor/Consultant|Merck: Grant/Research Support|Pfizer: Advisor/Consultant|Roche: Grant/Research Support|Shionogi: Advisor/Consultant|Shionogi: Grant/Research Support|Utility: Advisor/Consultant|Venatorx: Advisor/Consultant|Venatorx: Grant/Research Support…”
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    144. Impact of Rapid Identification and Resistance Gene Detection using an Algorithm-Based Approach in Gram-Negative Bacteremia
  5. 4265
    “…The mean time to first COVID-19 vaccine dose was 2.8 (±1.8) months from December 2020 (Pfizer-BioNTech vaccine approval), and time to first booster was 9.9 (±3.8) months from the date of the first vaccine. …”
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    2393. Factors Associated with Time to COVID-19 Vaccination among People with HIV
  6. 4266
    “….: Expert Testimony|Merck: Advisor/Consultant|Reminger Co., L.P.A: Expert Testimony|Spero: Advisor/Consultant|Takeda: Advisor/Consultant|Taylor, English, Duma, LLP: Expert Testimony|Third Pole Therapeutics: Advisor/Consultant Sarah K. Parker, MD, Pfizer: Grant/Research Support…”
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    2946. Comparative Pharmacokinetics and Pharmacodynamics of Cefadroxil and Cephalexin for Pediatric Musculoskeletal Infections
  7. 4267
    “…DISCLOSURES: Regina Simeone, PhD, Pfizer: Stocks/Bonds Natasha B. Halasa, MD, MPH, Merck: Grant/Research Support|Quidell: Grant/Research Support|Quidell: donation of kits|Sanofi: Grant/Research Support|Sanofi: vaccine support…”
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    461. COVID-19 Hospitalizations among Vaccinated and Unvaccinated Immunocompromised Children, 23 States, December 2022 – April 2023
  8. 4268
    “…DISCLOSURES: Mónica López-lacort, n/a, GSK: Grant/Research Support|Merck: Grant/Research Support|Merck: Honoraria|Sanofi: Grant/Research Support Kelly, D Johnson, n/a, Merck: Stocks/Bonds Miloje Savic, PhD, GSK Biologicals: Stocks/Bonds Alejandro Orrico-Sánchez, GSK: Grant/Research Support|Merck: Advisor/Consultant|Merck: Board Member|Merck: Grant/Research Support|Merck: Honoraria|Pfizer: Grant/Research Support|Sanofi: Board Member|Sanofi: Grant/Research Support|Sanofi: Honoraria…”
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    2592. The Incidence Rate Of Pneumococcal Pneumonia In Two European Aging Adults Population Using Real-World Data
  9. 4269
    “….: Royalties for chapters on pneumonia Sanjat Kanjilal, MD, MPH, GSK: Advisor/Consultant|Pattern biosciences: Advisor/Consultant|Roche: Honoraria|Uptodate: Royalties Chanu Rhee, MD, MPH, Cytovale: Advisor/Consultant|Pfizer: Advisor/Consultant|UpToDate, Inc.: Honoraria…”
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    2274. Trends in Empiric Antibiotic Utilization for Patients Hospitalized with Community-Onset SARS-CoV-2 Infections and Viral Sepsis During the COVID-19 Pandemic
  10. 4270
    “…DISCLOSURES: Zachary Willis, MD, MPH, Merck Sharp & Dohme Corp: Grant/Research Support|Pfizer Inc: Grant/Research Support…”
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    141. Impact of Diagnostic Stewardship of Respiratory Cultures in the Pediatric ICU
  11. 4271
    “….: Royalties for chapters on pneumonia Chanu Rhee, MD, MPH, Cytovale: Advisor/Consultant|Pfizer: Advisor/Consultant|UpToDate, Inc.: Honoraria…”
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    2326. SARS-CoV-2 PCR Cycle Threshold Trends in Immunocompromised Patients and Implications for Isolation Precautions
  12. 4272
    “…We have examined this possibility during prospective follow-up of adult onset hypopituitary patients enrolled in KIMS (Pfizer International Metabolic Database), a pharmacoepidemiological study of GH replacement in adult hypopituitary patients. …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Texto
    Growth hormone (GH) replacement decreases serum total and LDL-cholesterol in hypopituitary patients on maintenance HMG CoA reductase inhibitor (statin) therapy
  13. 4273
    “…McNeil, NIAID, NIH: Grant Investigator, Grant recipient. 
S. L. Kaplan, Pfizer: Grant Investigator and Speaker at PCV13 Launch Meeting in China, Research grant and Speaker honorarium…”
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    The Association of Molecular Characteristics, Vancomycin MIC and Clinical Outcomes in Methicillin-susceptible Staphylococcus aureus Osteoarticular Infections in Children
  14. 4274
    “….: Investigator, Grant recipient; MedImmune: Investigator, Grant recipient; Protein Science: Investigator, Grant recipient Pfizer: Investigator, Grant recipient…”
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    Effectiveness of Live Zoster Vaccine in Preventing Herpes Zoster Ophthalmicus (HZO)
  15. 4275
    “…Kumar, Sanofi: Speaker’s Bureau, Speaker honorarium. Pfizer: Speaker’s Bureau, Speaker honorarium. GSK: Grant Investigator, Grant recipient.…”
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    A Randomized Trial of High-dose Influenza Vaccine in Adult Solid-Organ Transplant Recipients
  16. 4276
    “…Zimmerman, Merck: Grant Investigator, Research grant; sanofi pasteur: Grant Investigator, Research grant; Pfizer: Grant Investigator, Research grant; M. P. …”
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    Influenza Vaccine Effectiveness in the United States During the 2016–2017 Season
  17. 4277
    “…DISCLOSURES: D. P. Kontoyiannis, Pfizer: Research Contractor, Research support and Speaker honorarium. …”
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    Invasive Mold Infections (IMIs) of the Central Nervous System (CNS) in Patients with Hematologic Cancer (HC) (2000–2016): Uncommon but Deadly
  18. 4278
    “…Marty, Astellas Pharma US: Consultant and Grant Investigator, Consulting fee and Grant recipient; Chimerix: Consultant and Grant Investigator, Consulting fee and Grant recipient; Fate Therapeutics: Scientific Advisor, Consulting fee; Gilead Sciences: Consultant and Grant Investigator, Consulting fee and Grant recipient; LFB: Consultant, Consulting fee; Merck: Consultant, Grant Investigator and Scientific Advisor, Consulting fee and Grant recipient; Roche Molecular Systems: Consultant, Consulting fee; Shire: Consultant and Grant Investigator, Consulting fee and Grant recipient; D. P. Kontoyiannis, Pfizer: Research Contractor, Research support and Speaker honorarium; Astellas: Research Contractor, Research support and Speaker honorarium; Merck: Honorarium, Speaker honorarium; Cidara: Honorarium, Speaker honorarium; Amplyx: Honorarium, Speaker honorarium; F2G: Honorarium, Speaker honorarium…”
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    Breath-Based Diagnosis of Invasive Mucormycosis (IM)
  19. 4279
    “…Syriopoulou, Hellenic Center for Disease Control and Prevention: Grant Investigator, Research grant. Pfizer Inc.Pharmaceutical Company: Grant Investigator, Research grant…”
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    Characteristics of Streptococcus pneumoniae Serotype 19A Isolates from Children in the Pre- and Post-Conjugate Vaccine Era
  20. 4280
    “…Therefore, lorlatinib may represent an effective therapeutic strategy for patients who have become resistant to currently available TKIs, including second-generation ALK TKIs in ALK-positive NSCLC. FUNDING: Pfizer…”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    Lorlatinib in ALK- or ROS1-rearranged non-small cell lung cancer: an international, multicenter, open-label phase 1 trial
Herramientas de búsqueda: RSS